Results 111 to 120 of about 2,115 (174)

Impact of proper surgical treatment on the survival of patients with epithelial ovary cancer. [PDF]

Rev Col Bras Cir, 2022
Faria FH, Lage APD, Rodrigues AN, Wainstein AJA.   +3 more
europepmc   +1 more source

Cáncer de ovario

, 1967
The author has studied 90 patients with cancer of the ovary at the Instituto Nacional de Enfermedades Neoplásicas, Lima from 1953-62; the overall age of the women was 47 years, and the histological classification as follows: 48.4% were serous carcinoma ...
Valdivia Ponce, Eduardo
core  

[PAPPS Expert Groups. Cancer prevention recommendations: Update 2022]. [PDF]

Aten Primaria, 2022
Marzo-Castillejo M, Bartolomé-Moreno C, Bellas-Beceiro B, Melús-Palazón E, Vela-Vallespín C.   +4 more
europepmc   +1 more source

[2018-2024 Cancer Trends in Pathology of a Hospital in Eastern Mexico]. [PDF]

Rev Med Inst Mex Seguro Soc
González-Zago A, Fierro-Atondo FA, Ramírez-Juárez N, Pérez-Corro MÁ, Anaya-Ruiz M, Maycotte P.   +5 more
europepmc   +1 more source

Cáncer de ovario

, 2001
El cáncer de ovario es una neoplasia poco común y así representa el 4 % de todos los cánceres que afectan a la mujer y el 20 % de los cánceres genitales. El riesgo de padecerlo es 1:70.
Martín Ortega, José Antonio
core  

Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer. [PDF]

Future Oncol
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melou AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Liu X, Nieuwenhuysen EV, DUO-E Investigators.   +29 more
europepmc   +1 more source

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line. [PDF]

Br J Cancer, 2023
Colombo N, Gadducci A, Sehouli J, Rulli E, Mäenpää J, Sessa C, Montes A, Ottevanger NB, Berger R, Vergote I, D'Incalci M, Churruca Galaz C, Chekerov R, Nyvang GB, Riniker S, Herbertson R, Fossati R, Barretina-Ginesta MP, Deryal M, Mirza MR, Biagioli E, Iglesias M, Funari G, Romeo M, Tasca G, Pardo B, Tognon G, Rubio-Pérez MJ, DeCensi A, De Giorgi U, Zola P, Benedetti Panici P, Aglietta M, Arcangeli V, Zamagni C, Bologna A, Westermann A, Heinzelmann-Schwarz V, Tsibulak I, Wimberger P, Poveda A, INOVATYON study group.   +41 more
europepmc   +1 more source

Papel de CXCR4 en la diseminación hematógena y intraperitoneal en el cáncer de ovario

El término cáncer de ovario se utiliza para definir todas aquellas neoplasias malignas que crecen en el ovario. Debido a esta definición meramente por su localización, este tipo de cáncer engloba a diferentes tipos de tumores, con características ...
Figueras i Amat, Agnès, Viñals Canals, Francesc   +1 more
core  

Long-Term Young Adult Cancer Survivors with Ovarian Cancer: Subgroup Analysis of the Study "Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer": The International NOGGO, ENGOT, and GCIG Survey. [PDF]

Cancers (Basel)
Dimitrova D, Samartzis EP, Zocholl D, Barretina-Ginesta MP, Leitner K, Havelka P, Achimas-Cadariu P, Taskiran C, Mittelstadt S, Van Nieuwenhuysen E, Bauerschmitz G, Heinzelmann-Schwarz V, Madariaga A, Ringsdorf U, Zwimpfer T, Madroñal C, Enzinger HM, Al Rubaish S, Sehouli J, Woopen H.   +19 more
europepmc   +1 more source

Ovarian sex cord tumor with annular tubules: case report and review of the literature [PDF]

Rev Colomb Obstet Ginecol, 2022
Ruiz-Echeverría FR, Beltrán-Salazar MI, Calderón-Quiroz PH, Lalinde-Triviño JD, Palencia-Palacios M, Suescún-Garay O.   +5 more
europepmc   +1 more source